Relevant bibliographies by topics / Antileukemic

Contents

  1. Journal articles
  2. Dissertations / Theses
  3. Books
  4. Book chapters
  5. Conference papers

Academic literature on the topic 'Antileukemic'

Author: Grafiati
Published: 9 March 2023
Last updated: 31 July 2025

Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles

Select a source type:

Consult the lists of relevant articles, books, theses, conference reports, and other scholarly sources on the topic 'Antileukemic.'

Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.

You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.

Journal articles on the topic "Antileukemic"

1

Kakar, Satinder, Anurekha Jain, and Ramandeep Singh. "In vivo study on murine species using Cytarabine magnetic microspheres." International Journal of Public Health Science (IJPHS) 9, no. 3 (2020): 255. http://dx.doi.org/10.11591/ijphs.v9i3.20468.

Full text
Abstract:
Cytarabine magnetic microspheres were formulated and checked for their antileukemic potential. Leukemia was persuaded in the Wister strain of rat by intravenous injection of benzene. Blood was procured and various hematological parameters were noted and compared. Animals were divided into four groups, antileukemial potential was found to be maximum in case of magnetic microspheres of Cytarabine. The study shows the Antileukemic potential of Cytarabine magnetic microspheres.
APA, Harvard, Vancouver, ISO, and other styles
2

Satinder, Kakar, Jain Anurekha, and Singh Ramandeep. "In vivo study on murine species using Cytarabine magnetic microspheres." International Journal of Public Health Science (IJPHS) 9, no. 3 (2020): 255~258. https://doi.org/10.11591/ijphs.v9i3.20468.

Full text
Abstract:
Cytarabine magnetic microspheres were formulated and checked for their antileukemic potential. Leukemia was persuaded in the Wister strain of rat by intravenous injection of benzene. Blood was procured and various hematological parameters were noted and compared. Animals were divided into four groups, antileukemial potential was found to be maximum in case of magnetic microspheres of Cytarabine. The study shows the Antileukemic potential of Cytarabine magnetic microspheres.
APA, Harvard, Vancouver, ISO, and other styles
3

Mantadakis, Elpis, and Maria Kalmanti. "New Antileukemic Agents." Pediatric Hematology and Oncology 20, no. 3 (2003): 173–85. http://dx.doi.org/10.1080/08880010390158928.

Full text
APA, Harvard, Vancouver, ISO, and other styles
4

Mantadakis, Elpis, and Maria Kalmanti. "New Antileukemic Agents." Pediatric Hematology and Oncology 20, no. 3 (2003): 173–85. http://dx.doi.org/10.1080/713842282.

Full text
APA, Harvard, Vancouver, ISO, and other styles
5

Schmetzer, Helga, Friedhelm R. Schuster, Raymund Buhmann, et al. "Immunotherapy of Acute MYELOID LEUKEMIA: ANTI-LEUKEMIC EFFECTS by Unprimed or Primed, Selected or Unselected Effector T-CELLS." Blood 114, no. 22 (2009): 5122. http://dx.doi.org/10.1182/blood.v114.22.5122.5122.

Full text
Abstract:
Abstract Abstract 5122 T-cells are the most important mediators of antileukemic reactions after allogeneic stemcelltransplantation (SCT) or donorlymphocyte-infusions (DLI) in patients (pts) with myeloid leukemias (AML,MDS), although relapses occur. Presentation of leukemic antigens (LAA) is improved by conversion of leukemic cells to leukemia derived DC (DCleu). Our hypothesis is, that myeloid blasts convert in vivo spontaneously to DCleu and prime CTL; moreover DCleu can be generated ex vivo from blasts and be used to prime T-cells enabling the generation of leukemia-specific CTL. Therefore (
APA, Harvard, Vancouver, ISO, and other styles
6

Sanchez-Martin, Marta, Alberto Ambesi-Impiombato, Yue Qin, et al. "Synergistic antileukemic therapies inNOTCH1-induced T-ALL." Proceedings of the National Academy of Sciences 114, no. 8 (2017): 2006–11. http://dx.doi.org/10.1073/pnas.1611831114.

Full text
Abstract:
TheNotch1gene is a major oncogenic driver and therapeutic target in T-cell acute lymphoblastic leukemia (T-ALL). However, inhibition of NOTCH signaling with γ-secretase inhibitors (GSIs) has shown limited antileukemic activity in clinical trials. Here we performed an expression-based virtual screening to identify highly active antileukemic drugs that synergize with NOTCH1 inhibition in T-ALL. Among these, withaferin A demonstrated the strongest cytotoxic and GSI-synergistic antileukemic effects in vitro and in vivo. Mechanistically, network perturbation analyses showed eIF2A-phosphorylation–me
APA, Harvard, Vancouver, ISO, and other styles
7

Altman, Jessica K., Amy Szilard, Bruce W. Konicek, et al. "Inhibition of Mnk kinase activity by cercosporamide and suppressive effects on acute myeloid leukemia precursors." Blood 121, no. 18 (2013): 3675–81. http://dx.doi.org/10.1182/blood-2013-01-477216.

Full text
Abstract:
Key Points The Mnk inhibitor cercosporamide suppresses human leukemic progenitors and exhibits antileukemic effects in a xenograft mouse model. Cercosporamide enhances the antileukemic effects of cytarabine in vitro and in vivo.
APA, Harvard, Vancouver, ISO, and other styles
8

Ranganathan, Parvathi, Xueyan Yu, Ramasamy Santhanam, et al. "Decitabine priming enhances the antileukemic effects of exportin 1 (XPO1) selective inhibitor selinexor in acute myeloid leukemia." Blood 125, no. 17 (2015): 2689–92. http://dx.doi.org/10.1182/blood-2014-10-607648.

Full text
Abstract:
Key Points Decitabine priming increases antileukemic effects of selinexor in AML in vitro and in vivo. Decitabine priming allows for decreasing the dose of selinexor in patients, thus increasing tolerability without affecting antileukemic activity.
APA, Harvard, Vancouver, ISO, and other styles
9

Dervieux, Thierry, Timothy L. Brenner, Yuen Y. Hon, et al. "De novo purine synthesis inhibition and antileukemic effects of mercaptopurine alone or in combination with methotrexate in vivo." Blood 100, no. 4 (2002): 1240–47. http://dx.doi.org/10.1182/blood-2002-02-0495.

Full text
Abstract:
Methotrexate (MTX) and mercaptopurine (MP) are widely used antileukemic agents that inhibit de novo purine synthesis (DNPS) as a mechanism of their antileukemic effects. To elucidate pharmacodynamic differences among children with acute lymphoblastic leukemia (ALL), DNPS was measured in leukemic blasts from newly diagnosed patients before and after therapy with these agents. Patients were randomized to receive low-dose MTX (LDMTX: 6 oral doses of 30 mg/m2) or high-dose MTX (HDMTX: intravenous 1 g/m2) followed by intravenous MP; or intravenous MP alone (1 g/m2), as initial therapy. At diagnosis
APA, Harvard, Vancouver, ISO, and other styles
10

Mikhailovna Donnik, Irina. "Bovine Anti-leukemic Measures for Improving Live-Stock Farms in Belgorod and Kemerovo Regions of Russia." Bioscience Biotechnology Research Communications 14, no. 4 (2021): 1548–90. http://dx.doi.org/10.21786/bbrc/14.4.33.

Full text
Abstract:
Bovine leukemia remains one of the most urgent viral diseases in veterinary medicine, and potentially dangerous for humans. The strategy of combating it is aimed at improving the existing measures and full recovery of agricultural enterprises. The quality of animal products is a priority in the field of food safety. The aim of the research was to develop effective antileukemic measures for the improvement of livestock farms in the Belgorod and Kemerovo regions. The proposed antileukemic measures are to increase the frequency of serological studies from 6-th months to the 2-3th months among ani
APA, Harvard, Vancouver, ISO, and other styles
More sources

Dissertations / Theses on the topic "Antileukemic"

1

Nanbakhsh, Arash. "Antileukemic activity of allogeneic NK Cells." Thesis, Paris 11, 2014. http://www.theses.fr/2014PA11T059.

Full text
Abstract:
Les cellules tueuses naturelles (NK pour Natural Killer) sont une population lymphoïde dotées d’une activité cytotoxique contre les cellules infectées ou les cellules cancéreuses. Les cellules NK ont un potentiel thérapeutique considérable en tant que thérapie cellulaire anti-tumorale, particulièrement dans le cadre des leucémies. Ces approches sont basées sur une amélioration de la production de cellules NK à partir de cellules souches hématopoïétiques (quantitative et qualitative en améliorant leur activité lytique), mais aussi sur une manipulation de la sensibilité des cellules leucémiques
APA, Harvard, Vancouver, ISO, and other styles
2

O'Connor, Brian 1961. "Studies towards the synthesis of the novel antileukemic agent CI-920 and the addition of cuprates to vinyltriphenylphosphonium bromide : a synthesis of 1,5-disubstituted 1Z,4Z-pentadienes." Thesis, McGill University, 1987. http://digitool.Library.McGill.CA:80/R/?func=dbin-jump-full&object_id=75443.

Full text
Abstract:
A new method for the preparation of 1,5-disubstituted-1Z,4Z-pentadienes by the addition of alkenyl cuprates to vinyltriphenylphosphonium bromide followed by an aldehyde is described. This method is used for the syntheses of 6Z,9Z-heneicosadiene and 15,15-(diethyldithio)-13S-t-butyldiphenylsilyloxy-6Z,9Z,11E-pentadecatriene. Syntheses of $(-)$-(5R)-argentilactone and (+)-(5R)-goniothalamin are described. Model studies towards the synthesis of the novel antileukemic agent CI-920 were carried out.
APA, Harvard, Vancouver, ISO, and other styles
3

Böck, Corinna Lesley [Verfasser], and Helga [Akademischer Betreuer] Schmetzer. "Significance of frequencies, compositions and/or antileukemic activity of (DC-stimulated) invariant NKT, NK and CIK cells on the outcome of patients with AML, ALL and CLL / Corinna Lesley Böck ; Betreuer: Helga Schmetzer." München : Universitätsbibliothek der Ludwig-Maximilians-Universität, 2018. http://d-nb.info/1162443499/34.

Full text
APA, Harvard, Vancouver, ISO, and other styles
4

Hirn, Lopez Annika [Verfasser], та Helga [Akademischer Betreuer] Schmetzer. "Role of Interferon (IFN)α in "Cocktails" for the generation of (leukemia-derived) dendritic cells (DCleu) from blasts in blood from patients (pts) with acute myeloid leukemia (AML) and the induction of antileukemic reactions / Annika Hirn Lopez ; Betreuer: Helga Schmetzer". München : Universitätsbibliothek der Ludwig-Maximilians-Universität, 2020. http://d-nb.info/1226092470/34.

Full text
APA, Harvard, Vancouver, ISO, and other styles
5

Lai, Kuei-Hung. "Studies on anti-leukemic terpenoids from medicinal mushrooms and marine sponges with ChemGPS-NP-based targets investigation of lead compounds." Doctoral thesis, Uppsala universitet, Avdelningen för farmakognosi, 2017. http://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-317554.

Full text
Abstract:
This thesis investigates the anti-leukemic activity of terpenoids isolated from medicinal mushrooms and marine sponges, as well as their possible targets and mechanisms of action. In the first section, we focused on studying the triterpenoidal components of three triterpenoid-enriched medicinal mushrooms Antrodia cinnamomea, Ganoderma lucidum, and Poria cocos, which have been used in folk medicine for centuries and also developed into several contemporary marketed products. We isolated the major and characteristic triterpenoids from these mushrooms, together with six new lanostanoids (II-1–II-
APA, Harvard, Vancouver, ISO, and other styles
6

Alsalim, Rana. "Contribution à la synthèse totale de la céphalotaxine." Thesis, Paris 11, 2013. http://www.theses.fr/2013PA114811/document.

Full text
Abstract:
Depuis plus de 40 ans des chimistes se sont intéressés à l’extraction, à l’activité biologique et à la synthèse de l’homoharringtonine, un ester naturel de la céphalotaxine, qui est un puissant antileucémique, en vue de son utilisation thérapeutique, en particulier contre les leucémies résistantes aux inhibiteurs de tyrosine kinase. Ces alcaloïdes sont extraits de Cephalotaxus, des conifères originaires du sud de la Chine à croissance extrêmement lente et menacés d’extinction, la synthèse de ces alcaloïdes est nécessaire pour une utilisation thérapeutique.L’objectif de ce travail consiste à dé
APA, Harvard, Vancouver, ISO, and other styles
7

Quteishat, Laith. "Contribution à la synthèse totale de la céphalotaxine." Thesis, Paris 11, 2013. http://www.theses.fr/2013PA114846/document.

Full text
Abstract:
Depuis plus de 40 ans des chimistes se sont intéressés à l’extraction, à l’activité biologique et à la synthèse de l’homoharringtonine (HHT), un ester naturel de la céphalotaxine, qui est un puissant antileucémique utilisé pour le traitement des leucémies résistantes aux inhibiteurs de tyrosine kinase. Ces alcaloïdes sont extraits de Cephalotaxus, des conifères originaires du sud de la Chine à croissance extrêmement lente et menacés d’extinction. Leur synthèse est donc nécessaire. L’homoharringtonine utilisée en thérapeutique est obtenue à partir de (-)-céphalotaxine d’origine naturelle, par g
APA, Harvard, Vancouver, ISO, and other styles
8

ZHANG, HONG-WU, and 張宏武. "Synthesis of cyclic dilysyl peptide-chlorambucil conjugates as novel potential antileukemic agents." Thesis, 1991. http://ndltd.ncl.edu.tw/handle/95003298616923645329.

Full text
APA, Harvard, Vancouver, ISO, and other styles
9

Adassi, Ines. "Evaluating the Antileukemic and Antiviral Activity of TH9402-Photodepleted Peripheral Blood Mononuclear Cells." Thèse, 2018. http://hdl.handle.net/1866/22800.

Full text
APA, Harvard, Vancouver, ISO, and other styles
10

Chuang, Wen-Chen, and 莊文貞. "Study on the Antileukemic Immunity of Dunalella salina and Hepatoprotective Activity of Hydrogen-Rich Water in Mice." Thesis, 2015. http://ndltd.ncl.edu.tw/handle/q88h28.

Full text
Abstract:
博士<br>國立中興大學<br>獸醫學系暨研究所<br>103<br>part 1 Dunaliella salina (D. salina) has been shown to have antioxidant property and induce apoptotic cell death of human cancer cell in vitro. However, there is no information available on anti-leukemia effect or immunomodulatory activity in vivo. In this study, we applied D. salina to syngeneic leukemia-implanted mice (BALB/c and WEHI-3) to investigate its immunological and anti-leukemia properties. Oral administration of D. salina (184.5, 369 and 922.5 mg/kg) for 4 weeks could inhibit tumor metastasis into spleen and liver, and prolonged the survival rate
APA, Harvard, Vancouver, ISO, and other styles
More sources

Books on the topic "Antileukemic"

1

Ingram, B. A. Identification of factors inducing catharanthine (an antileukemic drug) production in immobilised catharanthus roseus cultures. UMIST, 1993.

Find full text
APA, Harvard, Vancouver, ISO, and other styles

Book chapters on the topic "Antileukemic"

1

Catanzaro, Elena, and Carmela Fimognari. "Antileukemic Activity of Sulforaphane." In Glucosinolates. Springer International Publishing, 2016. http://dx.doi.org/10.1007/978-3-319-26479-0_14-1.

Full text
APA, Harvard, Vancouver, ISO, and other styles
2

Catanzaro, Elena, and Carmela Fimognari. "Antileukemic Activity of Sulforaphane." In Reference Series in Phytochemistry. Springer International Publishing, 2017. http://dx.doi.org/10.1007/978-3-319-25462-3_14.

Full text
APA, Harvard, Vancouver, ISO, and other styles
3

Schmiegelow, Kjeld, and Inge van der Sluis. "Pharmacokinetics, Pharmacodynamics and Pharmacogenetics of Antileukemic Drugs." In Childhood Acute Lymphoblastic Leukemia. Springer International Publishing, 2017. http://dx.doi.org/10.1007/978-3-319-39708-5_5.

Full text
APA, Harvard, Vancouver, ISO, and other styles
4

Riccardi, Riccardo, Anna Lasorella, and Renato Mastrangelo. "Factors affecting the clinical pharmacology of antileukemic drugs." In The Role of Pharmacology in Pediatric Oncology. Springer Netherlands, 1987. http://dx.doi.org/10.1007/978-94-009-4267-7_12.

Full text
APA, Harvard, Vancouver, ISO, and other styles
5

Mow, Benjamin M. F., and Scott H. Kaufmann. "Targeting the Apoptotic Machinery as a Potential Antileukemic Strategy." In Biologic Therapy of Leukemia. Humana Press, 2003. https://doi.org/10.1007/978-1-59259-383-5_11.

Full text
APA, Harvard, Vancouver, ISO, and other styles
6

Amin, Insha, Arif Ali, Bilal Ahmad Mir, et al. "Molecular Mechanistic Approach of Important Antileukemic Compounds Present in Honey." In Therapeutic Applications of Honey and its Phytochemicals. Springer Singapore, 2020. http://dx.doi.org/10.1007/978-981-15-7305-7_1.

Full text
APA, Harvard, Vancouver, ISO, and other styles
7

Bonini, Chiara, Marina Cavazzana, Fabio Ciceri, Boris Fehse, and Michael Hudecek. "Cellular Therapy with Engineered T Cells, Efficacy, and Side Effects: Gene Editing/Gene Therapy." In The EBMT Handbook. Springer International Publishing, 2024. http://dx.doi.org/10.1007/978-3-031-44080-9_60.

Full text
Abstract:
AbstractThe cellular basis of cancer immune surveillance, already hypothesized in ancient times, was only proven with the advent of HCT. Indeed, the discovery of the nature of GVHD and its antileukemic effects (Weiden et al. 1979) was followed by the first successful attempts of adoptive immunotherapy using donor leukocytes (Kolb et al. 1990). To address the significant GVHD risk associated with allogeneic T cells, several approaches of T-cell manipulation were developed and tested (Table 60.1). Some of these strategies rely on the genetic manipulation of T cells. First, suicide gene therapy a
APA, Harvard, Vancouver, ISO, and other styles
8

Essink, M. E., W. Hiddemann, M. von Eiff, Th Büchner, and J. van de Loo. "Effect of Antifungal Therapy on Hematological Recovery After Intensive Antileukemic Chemotherapy." In Acute Leukemias II. Springer Berlin Heidelberg, 1990. http://dx.doi.org/10.1007/978-3-642-74643-7_100.

Full text
APA, Harvard, Vancouver, ISO, and other styles
9

Mihál, Vladimír, Marián Hajdúch, Věra Nosková, et al. "Differential Antileukemic Activity of Prednisolone and Dexamethasone in Freshly Isolated Leukemic Cells." In Drug Resistance in Leukemia and Lymphoma III. Springer US, 1999. http://dx.doi.org/10.1007/978-1-4615-4811-9_50.

Full text
APA, Harvard, Vancouver, ISO, and other styles
10

Runde, V., C. Aul, A. Heyll, and W. Schneider. "Intensive Antileukemic Treatment for Advanced Primary Myelodysplastic Syndromes: Analysis of 30 Patients." In Acute Leukemias. Springer Berlin Heidelberg, 1992. http://dx.doi.org/10.1007/978-3-642-76591-9_79.

Full text
APA, Harvard, Vancouver, ISO, and other styles

Conference papers on the topic "Antileukemic"

1

Moses, Blake S., Jennifer M. Fox, Xiaochun Chen, et al. "Abstract 2023: Artemisinins enhanced the antileukemic efficacy of BCL2 inhibitors." In Proceedings: AACR Annual Meeting 2017; April 1-5, 2017; Washington, DC. American Association for Cancer Research, 2017. http://dx.doi.org/10.1158/1538-7445.am2017-2023.

Full text
APA, Harvard, Vancouver, ISO, and other styles
2

Castellano, Gloria, Adela León, and Francisco Torrens. "Quantitative Structure-Antileukemic Activity Models of stilbenoids: A Theoretical Study." In MOL2NET 2018, International Conference on Multidisciplinary Sciences, 4th edition. MDPI, 2018. http://dx.doi.org/10.3390/mol2net-04-05903.

Full text
APA, Harvard, Vancouver, ISO, and other styles
3

Sanchez-Martin, Marta, Alberto Ambesi-Impiombato, Yue Qin, et al. "Abstract 49: Synergistic antileukemic therapies in NOTCH1-induced T-ALL." In Abstracts: Second AACR Conference on Hematologic Malignancies: Translating Discoveries to Novel Therapies; May 6-9, 2017; Boston, MA. American Association for Cancer Research, 2017. http://dx.doi.org/10.1158/1557-3265.hemmal17-49.

Full text
APA, Harvard, Vancouver, ISO, and other styles
4

Vandenberghe-Huez, Isabelle, Arnaud Pillon, Laurent Créancier, et al. "Abstract 2747: Synergistic antileukemic activity of F14512 in combination with AraC." In Proceedings: AACR 103rd Annual Meeting 2012‐‐ Mar 31‐Apr 4, 2012; Chicago, IL. American Association for Cancer Research, 2012. http://dx.doi.org/10.1158/1538-7445.am2012-2747.

Full text
APA, Harvard, Vancouver, ISO, and other styles
5

Kruczynski, Anna, Christian Recher, Sandrine Pourtau, et al. "Abstract B186: Preclinical antileukemic activity of F14512, a novel targeted cytotoxic agent." In Abstracts: AACR-NCI-EORTC International Conference: Molecular Targets and Cancer Therapeutics--Nov 15-19, 2009; Boston, MA. American Association for Cancer Research, 2009. http://dx.doi.org/10.1158/1535-7163.targ-09-b186.

Full text
APA, Harvard, Vancouver, ISO, and other styles
6

Vázquez, Ramiro, María E. Riveiro, Eliana Alonso, et al. "Abstract 3262: Pharmaco-modulation of dihydroxy coumarins towards more selective antileukemic agents." In Proceedings: AACR 102nd Annual Meeting 2011‐‐ Apr 2‐6, 2011; Orlando, FL. American Association for Cancer Research, 2011. http://dx.doi.org/10.1158/1538-7445.am2011-3262.

Full text
APA, Harvard, Vancouver, ISO, and other styles
7

Larrue, Clément, Stéphane Manenti, and Christian Récher. "Abstract 5482: Antileukemic activity of 2-deoxy-d-glucose in acute myeloid leukemia." In Proceedings: AACR Annual Meeting 2014; April 5-9, 2014; San Diego, CA. American Association for Cancer Research, 2014. http://dx.doi.org/10.1158/1538-7445.am2014-5482.

Full text
APA, Harvard, Vancouver, ISO, and other styles
8

Zaharieva, Maya M., Milen Kirilov, Minquang Chai, Stefan M. Berger, Spiro M. Konstantinov, and Martin R. Berger. "Abstract 4352: Down regulation of retinoblastoma protein expressionimpedes the antileukemic activity of erufosine." In Proceedings: AACR 104th Annual Meeting 2013; Apr 6-10, 2013; Washington, DC. American Association for Cancer Research, 2013. http://dx.doi.org/10.1158/1538-7445.am2013-4352.

Full text
APA, Harvard, Vancouver, ISO, and other styles
9

Wu, Edward J., Dennis J. Goussetis, and Leonidas C. Platanias. "Abstract 590: Enhancing effect of resveratrol on the antileukemic effects of arsenic trioxide." In Proceedings: AACR 104th Annual Meeting 2013; Apr 6-10, 2013; Washington, DC. American Association for Cancer Research, 2013. http://dx.doi.org/10.1158/1538-7445.am2013-590.

Full text
APA, Harvard, Vancouver, ISO, and other styles
10

Pesakhov, Stella, Marina Khanin, George P. Studzinski, and Michael Danilenko. "Abstract 3491: Differential antileukemic activity of plant polyphenol combinations in acute myeloid leukemia (AML) cells." In Proceedings: AACR 101st Annual Meeting 2010‐‐ Apr 17‐21, 2010; Washington, DC. American Association for Cancer Research, 2010. http://dx.doi.org/10.1158/1538-7445.am10-3491.

Full text
APA, Harvard, Vancouver, ISO, and other styles
You might also be interested in the extended bibliographies on the topic 'Antileukemic' for particular source types:
Journal articles Dissertations / Theses
We offer discounts on all premium plans for authors whose works are included in thematic literature selections. Contact us to get a unique promo code!

To the bibliography